Pharmacokinetics of Drugs [electronic resource] /

Pharmacokinetics of Drugs [electronic resource] /

Show other versions (1)

The author of this Foreword has recently retired after spending 25 years in academia and 15 years in the pharmaceutical industry. Most of this time has been spent following and, hopefully in some instances, contributing to advancement of the discipline of pharmacokinetics. During the last 40 years, pharmacokinetics has grown from a fledgling in the 1950s to an adult in the 1990s. The late development of the discipline of pharmacokinetics, relative to other disciplines such as chemistry, bio­ chemistry, and pharmacology, probably stems both from general ignorance of the importance of the time course of concentration-effect relationships in drug therapy and from our technical inability to do anything about it had we been more enlightened. Just as the end of the historical dark ages had to await the beginning of the Carolingian revival, so the end of the pharma­ co kinetic dark age had to await the discovery of adequate analytical methods and also an intellectual leap of faith to accept that drug action is in some way dependent on receptor site occupancy, and therefore on drug con­ centration. The recent evolution of pharmacokinetics has occurred in three phases which may be identified as those of discovery, stabilization, and rationaliz­ ation. The discovery phase, which occurred in the 1950s and 1960s, esta­ blished the mathematics and concepts of "modern" pharmacokinetics and sought areas of application, ranging from model-independent methods, through compartment approaches, to complex physiological models.

Saved in:
Bibliographic Details
Main Authors: Welling, Peter G. editor., Balant, Luc P. editor., SpringerLink (Online service)
Format: Texto biblioteca
Language:eng
Published: Berlin, Heidelberg : Springer Berlin Heidelberg, 1994
Subjects:Medicine., Human physiology., Pharmacology., Nuclear medicine., Internal medicine., Biomedicine., Pharmacology/Toxicology., Human Physiology., Internal Medicine., Nuclear Medicine.,
Online Access:http://dx.doi.org/10.1007/978-3-642-78680-8
Tags: Add Tag
No Tags, Be the first to tag this record!
id KOHA-OAI-TEST:194488
record_format koha
institution COLPOS
collection Koha
country México
countrycode MX
component Bibliográfico
access En linea
En linea
databasecode cat-colpos
tag biblioteca
region America del Norte
libraryname Departamento de documentación y biblioteca de COLPOS
language eng
topic Medicine.
Human physiology.
Pharmacology.
Nuclear medicine.
Internal medicine.
Biomedicine.
Pharmacology/Toxicology.
Human Physiology.
Internal Medicine.
Nuclear Medicine.
Medicine.
Human physiology.
Pharmacology.
Nuclear medicine.
Internal medicine.
Biomedicine.
Pharmacology/Toxicology.
Human Physiology.
Internal Medicine.
Nuclear Medicine.
spellingShingle Medicine.
Human physiology.
Pharmacology.
Nuclear medicine.
Internal medicine.
Biomedicine.
Pharmacology/Toxicology.
Human Physiology.
Internal Medicine.
Nuclear Medicine.
Medicine.
Human physiology.
Pharmacology.
Nuclear medicine.
Internal medicine.
Biomedicine.
Pharmacology/Toxicology.
Human Physiology.
Internal Medicine.
Nuclear Medicine.
Welling, Peter G. editor.
Balant, Luc P. editor.
SpringerLink (Online service)
Pharmacokinetics of Drugs [electronic resource] /
description The author of this Foreword has recently retired after spending 25 years in academia and 15 years in the pharmaceutical industry. Most of this time has been spent following and, hopefully in some instances, contributing to advancement of the discipline of pharmacokinetics. During the last 40 years, pharmacokinetics has grown from a fledgling in the 1950s to an adult in the 1990s. The late development of the discipline of pharmacokinetics, relative to other disciplines such as chemistry, bio­ chemistry, and pharmacology, probably stems both from general ignorance of the importance of the time course of concentration-effect relationships in drug therapy and from our technical inability to do anything about it had we been more enlightened. Just as the end of the historical dark ages had to await the beginning of the Carolingian revival, so the end of the pharma­ co kinetic dark age had to await the discovery of adequate analytical methods and also an intellectual leap of faith to accept that drug action is in some way dependent on receptor site occupancy, and therefore on drug con­ centration. The recent evolution of pharmacokinetics has occurred in three phases which may be identified as those of discovery, stabilization, and rationaliz­ ation. The discovery phase, which occurred in the 1950s and 1960s, esta­ blished the mathematics and concepts of "modern" pharmacokinetics and sought areas of application, ranging from model-independent methods, through compartment approaches, to complex physiological models.
format Texto
topic_facet Medicine.
Human physiology.
Pharmacology.
Nuclear medicine.
Internal medicine.
Biomedicine.
Pharmacology/Toxicology.
Human Physiology.
Internal Medicine.
Nuclear Medicine.
author Welling, Peter G. editor.
Balant, Luc P. editor.
SpringerLink (Online service)
author_facet Welling, Peter G. editor.
Balant, Luc P. editor.
SpringerLink (Online service)
author_sort Welling, Peter G. editor.
title Pharmacokinetics of Drugs [electronic resource] /
title_short Pharmacokinetics of Drugs [electronic resource] /
title_full Pharmacokinetics of Drugs [electronic resource] /
title_fullStr Pharmacokinetics of Drugs [electronic resource] /
title_full_unstemmed Pharmacokinetics of Drugs [electronic resource] /
title_sort pharmacokinetics of drugs [electronic resource] /
publisher Berlin, Heidelberg : Springer Berlin Heidelberg,
publishDate 1994
url http://dx.doi.org/10.1007/978-3-642-78680-8
work_keys_str_mv AT wellingpetergeditor pharmacokineticsofdrugselectronicresource
AT balantlucpeditor pharmacokineticsofdrugselectronicresource
AT springerlinkonlineservice pharmacokineticsofdrugselectronicresource
_version_ 1756266612329021440
spelling KOHA-OAI-TEST:1944882018-07-30T23:20:01ZPharmacokinetics of Drugs [electronic resource] / Welling, Peter G. editor. Balant, Luc P. editor. SpringerLink (Online service) textBerlin, Heidelberg : Springer Berlin Heidelberg,1994.engThe author of this Foreword has recently retired after spending 25 years in academia and 15 years in the pharmaceutical industry. Most of this time has been spent following and, hopefully in some instances, contributing to advancement of the discipline of pharmacokinetics. During the last 40 years, pharmacokinetics has grown from a fledgling in the 1950s to an adult in the 1990s. The late development of the discipline of pharmacokinetics, relative to other disciplines such as chemistry, bio­ chemistry, and pharmacology, probably stems both from general ignorance of the importance of the time course of concentration-effect relationships in drug therapy and from our technical inability to do anything about it had we been more enlightened. Just as the end of the historical dark ages had to await the beginning of the Carolingian revival, so the end of the pharma­ co kinetic dark age had to await the discovery of adequate analytical methods and also an intellectual leap of faith to accept that drug action is in some way dependent on receptor site occupancy, and therefore on drug con­ centration. The recent evolution of pharmacokinetics has occurred in three phases which may be identified as those of discovery, stabilization, and rationaliz­ ation. The discovery phase, which occurred in the 1950s and 1960s, esta­ blished the mathematics and concepts of "modern" pharmacokinetics and sought areas of application, ranging from model-independent methods, through compartment approaches, to complex physiological models.A. Introduction -- 1 Role of Pharmacokinetics in Drug Discovery and Development -- B. Analytical Methods -- 2 Contemporary Aspects of Radioimmunoassay Development for Drug Analysis -- 3 Mass Spectrometry in Drug Disposition and Pharmacokinetics -- 4 Analytical Methods for Biotechnology Products -- C. In Vitro Methods-Protein and Tissue Binding -- 5 Metabolism: Scaling-up from In Vitro to Organ and Whole Body -- 6 Gastrointestinal Transport of Peptide and Protein Drugs and Prodrugs -- D. Classical Problems -- 7 Stereoselectivity in Metabolic Reactions of Toxication and Detoxication -- 8 Interethnic Differences in Drug Disposition and Response: Relevance for Drug Development, Licensing, and Registration -- 9 Clinical Relevance of Pharmacogenetics -- 10 Role of Environmental Factors in the Pharmacokinetics of Drugs: Considerations with Respect to Animal Models, P-450 Enzymes, and Probe Drugs -- 11 Time Course of Drug Effect -- E. Future Trends in Pharmacokinetics -- 12 Biotechnology Products -- 13 Peptide and Protein Drugs -- 14 Toxicokinetics -- 15 The Population Approach: Rationale, Methods, and Applications in Clinical Pharmacology and Drug Development -- F. Impact of New Methods on Pharmacokinetics -- 16 Contribution of Positron Emission Tomography to Pharmacokinetic Studies -- 17 In Vivo Imaging in Drug Discovery and Design -- G. Appendix -- 18 Considerations on Data Analysis Using Computer Methods and Currently Available Software for Personal Computers.The author of this Foreword has recently retired after spending 25 years in academia and 15 years in the pharmaceutical industry. Most of this time has been spent following and, hopefully in some instances, contributing to advancement of the discipline of pharmacokinetics. During the last 40 years, pharmacokinetics has grown from a fledgling in the 1950s to an adult in the 1990s. The late development of the discipline of pharmacokinetics, relative to other disciplines such as chemistry, bio­ chemistry, and pharmacology, probably stems both from general ignorance of the importance of the time course of concentration-effect relationships in drug therapy and from our technical inability to do anything about it had we been more enlightened. Just as the end of the historical dark ages had to await the beginning of the Carolingian revival, so the end of the pharma­ co kinetic dark age had to await the discovery of adequate analytical methods and also an intellectual leap of faith to accept that drug action is in some way dependent on receptor site occupancy, and therefore on drug con­ centration. The recent evolution of pharmacokinetics has occurred in three phases which may be identified as those of discovery, stabilization, and rationaliz­ ation. The discovery phase, which occurred in the 1950s and 1960s, esta­ blished the mathematics and concepts of "modern" pharmacokinetics and sought areas of application, ranging from model-independent methods, through compartment approaches, to complex physiological models.Medicine.Human physiology.Pharmacology.Nuclear medicine.Internal medicine.Biomedicine.Pharmacology/Toxicology.Human Physiology.Internal Medicine.Nuclear Medicine.Springer eBookshttp://dx.doi.org/10.1007/978-3-642-78680-8URN:ISBN:9783642786808

Similar Items